Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Other Working Capital Changes (2022 - 2025)

Gossamer Bio's Other Working Capital Changes history spans 4 years, with the latest figure at $7.7 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 645.31% year-over-year to $7.7 million; the TTM value through Dec 2025 reached $8.5 million, up 149.65%, while the annual FY2025 figure was $8.5 million, 149.65% up from the prior year.
  • Other Working Capital Changes reached $7.7 million in Q4 2025 per GOSS's latest filing, up from -$4.6 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $7.7 million in Q4 2025 to a low of -$5.1 million in Q3 2023.
  • Average Other Working Capital Changes over 4 years is $1.2 million, with a median of $1.0 million recorded in 2024.
  • The largest YoY upside for Other Working Capital Changes was 1285.25% in 2023 against a maximum downside of 2452.26% in 2023.
  • A 4-year view of Other Working Capital Changes shows it stood at $1.6 million in 2022, then skyrocketed by 91.91% to $3.0 million in 2023, then crashed by 65.65% to $1.0 million in 2024, then surged by 645.31% to $7.7 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Other Working Capital Changes are $7.7 million (Q4 2025), -$4.6 million (Q3 2025), and $5.3 million (Q2 2025).